Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Meningococcal Group C Immunisation

This leaflet is about protecting against the bacterium (germ) called Group C Neisseria meningitidis, also known as Group C meningococcus. Infection with this bacterium can cause meningitis and septicaemia (serious blood infection). All people under the age of 25 should be immunised and it is now a routine part of the childhood immunisation programme.

What is the meningococcus?

The meningococcus is a bacterium (germ) that can cause meningitis and septicaemia (blood infection). These infections are very serious and can be fatal if not treated quickly. There are different groups (strains or types) of meningococcal bacteria:

  • Groups B and C are the common strains in the UK. Most cases of bacterial meningitis in the UK are caused by Group B. Most of the rest are caused by Group C (although the number of Group C cases has fallen greatly due to immunisation introduced in 1999).
  • Group A is rare in the UK, but more common in certain parts of the world - in particular, in Sub-Saharan Africa and parts of Saudi Arabia.
  • Groups Y, W135, 29E and Z are rare in the UK but Group W135 has been the cause of recent outbreaks in certain parts of the world.

Infection with the meningococcus can affect anyone, but those most at risk are: children aged under five years, teenagers and young adults under the age of 25.

The meningitis C vaccine

A vaccine to protect against the Group C meningococcus (MenC vaccine) was launched in 1999. This vaccine protects against Group C only and not against Group A or B meningococcus. (See separate leaflet called 'Meningococcal Immunisation' for details of other vaccines against other groups of meningitis, which are used for travellers to at-risk countries.) The Men C vaccine is thought to give lifelong immunity, so booster doses later in life are not needed.

Who should be immunised?

Babies

Babies are given the MenC vaccine as part of the routine immunisation programme. Three doses (injections) of vaccine are needed for full protection. These are normally given at ages 3, 4 and 12 months. The first two doses are usually given at the same time as the routine DTaP/IPV(polio)/Hib vaccine (as a separate injection). ('DTaP/IPV(polio)/Hib' stands for 'diphtheria, tetanus, pertussis (whooping cough)/polio/Haemophilus influenzae type b'.) The third dose is a combined injection with the Hib vaccine.

Others

Older children, teenagers, and young adults under the age of 25 were offered immunisation in a catch up programme after the immunisation was introduced in 1999. Most are now immunised. However, if you are under 25 and have not been immunised, see your practice nurse to get immunised. Just one injection of vaccine is needed for those over the age of one year. Once all people under the age of 25 are immunised, only the routine immunisations for new babies will need to continue.

Close contacts of people with meningitis or septicaemia caused by Group C meningococcus may be offered the vaccine if they have not been previously immunised.

Are there any side-effects to the vaccine?

Most people have no side-effects. Sometimes a mild fever develops for a short time. Some babies become irritable for a short time after the injection. Slight swelling and redness at the injection site may occur. Headache and muscle aches for a short time are reported by some older children.

None of the above side-effects is serious, and they soon settle. If necessary, you can give paracetamol or ibuprofen to children to ease pain and fever following immunisation. Serious reactions are rare.

Who should not be immunised?

  • Immunisation should be postponed if a child has a high fever or serious infection. Minor infections such as coughs, colds and snuffles are no reason to postpone immunisation.
  • The vaccine should not be given if there has been a severe reaction to a previous dose of vaccine (which is extremely rare). Also, it should not be given if a person is known to be allergic to any of the ingredients in the vaccine. (These include extracts of meningococcal bacteria, diphtheria and tetanus toxoids and certain carrier proteins.)

Are you still at risk of meningitis after the immunisation?

Yes. However, this vaccine has greatly reduced the number of cases of meningitis and septicaemia since it was introduced in 1999.

Other groups of meningococcus, and other types of bacteria can still cause meningitis. Get medical help immediately if you suspect that your child, or someone you know, has meningitis or septicaemia. The earlier the treatment of meningitis or septicaemia, the better the chance of recovery and preventing complications or death. See separate leaflets called 'Meningitis and Septicaemia' and 'Meningitis - Symptom Checklist' for more details about the symptoms of meningitis and septicaemia.

Further information

Information on immunisation from the NHS

Web: www.nhs.uk/Planners/vaccinations/Pages/Vaccinationchecklist.aspx

References and Disclaimer | Provide feedback

References


Comprehensive patient resources are available at www.patient.co.uk

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
© EMIS 2011    Reviewed: 4 Feb 2011   DocID: 4540   Version: 40
For the planned review period see the Data Creation and Quality Control Process.